title: In vitro methods to complement in vivo approaches utilizing combinations of chemotherapy and immunotherapy.
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001761:Bleomycin / Q000494:pharmacology / Q000627:therapeutic use; D002330:Carmustine / Q000494:pharmacology / Q000627:therapeutic use; D002478:Cells, Cultured; D002645:Chickens; D002999:Clone Cells / Q000187:drug effects; D003208:Concanavalin A; D046508:Culture Techniques; D003561:Cytarabine / Q000494:pharmacology / Q000627:therapeutic use; D003584:Cytological Techniques; D004351:Drug Resistance; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D037102:Lectins; D008070:Lipopolysaccharides; D008214:Lymphocytes / Q000187:drug effects; D008545:Melanoma / Q000188:drug therapy; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000276:immunology; D013936:Thymidine / Q000378:metabolism
chemical_list: D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D037102:Lectins; D008070:Lipopolysaccharides; D003561:Cytarabine; D003208:Concanavalin A; D001761:Bleomycin; D002330:Carmustine; D013936:Thymidine